It has been reported that EGFR is highly-expressed in melanoma, and its expression level is positively correlated with tumor progression and poor prognosis [35], hence it might be a useful target to inhibit melanoma via inhibiting the expression of EGFR. The gene discussed is EGFR; the disease is melanoma.